These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 28596685)

  • 1. Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma.
    Wang T; Liu M; Zheng SJ; Bian DD; Zhang JY; Yao J; Zheng QF; Shi AM; Li WH; Li L; Chen Y; Wang JH; Duan ZP; Dong L
    World J Gastroenterol; 2017 May; 23(19):3496-3504. PubMed ID: 28596685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma.
    Liu M; Varela-Ramirez A; Li J; Dai L; Aguilera RJ; Zhang JY
    Oncol Rep; 2015 May; 33(5):2245-52. PubMed ID: 25779011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cancer-related protein 14-3-3ζ is a potential tumor-associated antigen in immunodiagnosis of hepatocellular carcinoma.
    Liu M; Liu X; Ren P; Li J; Chai Y; Zheng SJ; Chen Y; Duan ZP; Li N; Zhang JY
    Tumour Biol; 2014 May; 35(5):4247-56. PubMed ID: 24390614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel immunodiagnosis panel for hepatocellular carcinoma based on bioinformatics and the autoantibody-antigen system.
    Wu J; Wang P; Han Z; Li T; Yi C; Qiu C; Yang Q; Sun G; Dai L; Shi J; Wang K; Ye H
    Cancer Sci; 2022 Feb; 113(2):411-422. PubMed ID: 34821436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma.
    Dai L; Ren P; Liu M; Imai H; Tan EM; Zhang JY
    Clin Immunol; 2014; 152(1-2):127-39. PubMed ID: 24667685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum anti-Ku86: a potential biomarker for early detection of hepatocellular carcinoma].
    Chu L; Zhang X; Wang G; Zhou W; Du Z; Liu A; Zhao H
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):123-7. PubMed ID: 24796461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibody response to murine double minute 2 protein in immunodiagnosis of hepatocellular carcinoma.
    Liu M; Zheng SJ; Chen Y; Li N; Ren PF; Dai LP; Duan ZP; Zhang JY
    J Immunol Res; 2014; 2014():906532. PubMed ID: 24955377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma.
    Welberry C; Macdonald I; McElveen J; Parsy-Kowalska C; Allen J; Healey G; Irving W; Murray A; Chapman C
    PLoS One; 2020; 15(5):e0232247. PubMed ID: 32374744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyses of autoantibodies against tumor-associated antigens in patients with hepatocellular carcinoma.
    Himoto T; Kuriyama S; Zhang JY; Chan EK; Kimura Y; Masaki T; Uchida N; Nishioka M; Tan EM
    Int J Oncol; 2005 Oct; 27(4):1079-85. PubMed ID: 16142326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma.
    Chen Y; Zhou Y; Qiu S; Wang K; Liu S; Peng XX; Li J; Tan EM; Zhang JY
    Cancer Lett; 2010 Mar; 289(1):32-9. PubMed ID: 19683863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of an Autoantibody Panel and Alpha-Fetoprotein for Early Detection of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Shen Y; Chen J; Wu J; Li T; Yi C; Wang K; Wang P; Sun C; Ye H
    Cancer Prev Res (Phila); 2024 May; 17(5):227-235. PubMed ID: 38489403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of annexin A2 and as potential biomarkers for hepatocellular carcinoma.
    El-Abd N; Fawzy A; Elbaz T; Hamdy S
    Tumour Biol; 2016 Jan; 37(1):211-6. PubMed ID: 26189841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies against glucose-regulated protein 78 as serological diagnostic biomarkers in hepatocellular carcinoma.
    Shao Q; Ren P; Li Y; Peng B; Dai L; Lei N; Yao W; Zhao G; Li L; Zhang J
    Int J Oncol; 2012 Sep; 41(3):1061-7. PubMed ID: 22692946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibody response to Sui1 and its tissue-specific expression in hepatocellular carcinoma.
    Zhou JW; Li Y; Yue LX; Luo CL; Chen Y; Zhang JY
    Tumour Biol; 2016 Feb; 37(2):2547-53. PubMed ID: 26386724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of alpha-1-fetoprotein (AFP) as a biomarker for hepatocellular carcinoma recurrence after liver transplantation.
    Nörthen A; Asendorf T; Walson PD; Oellerich M
    Clin Biochem; 2018 Feb; 52():20-25. PubMed ID: 29054441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.
    Leerapun A; Suravarapu SV; Bida JP; Clark RJ; Sanders EL; Mettler TA; Stadheim LM; Aderca I; Moser CD; Nagorney DM; LaRusso NF; de Groen PC; Menon KV; Lazaridis KN; Gores GJ; Charlton MR; Roberts RO; Therneau TM; Katzmann JA; Roberts LR
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):394-402; quiz 267. PubMed ID: 17368240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of DKK1 and AFP improves diagnostic accuracy of hepatocellular carcinoma compared with either marker alone.
    Erdal H; Gül Utku Ö; Karatay E; Çelik B; Elbeg Ş; Doğan İ
    Turk J Gastroenterol; 2016 Jul; 27(4):375-81. PubMed ID: 27458854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of anti-SF3B1 autoantibody as a diagnostic marker in patients with hepatocellular carcinoma.
    Hwang HM; Heo CK; Lee HJ; Kwak SS; Lim WH; Yoo JS; Yu DY; Lim KJ; Kim JY; Cho EW
    J Transl Med; 2018 Jun; 16(1):177. PubMed ID: 29954402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
    Lim TS; Kim DY; Han KH; Kim HS; Shin SH; Jung KS; Kim BK; Kim SU; Park JY; Ahn SH
    Scand J Gastroenterol; 2016 Mar; 51(3):344-53. PubMed ID: 26340708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.